Tag: Vaccine

Categories
Business

Winter storm delays shipments of 6 million Covid vaccine doses in U.S.: Officers

Winter storm delays shipments of 6 million Covid vaccine doses in U.S.: Officials

On February 18, 2021, vehicles will be idle on Interstate Highway 35 heading south in Killeen, Texas.

Joe Raedle | Getty Images

Massive winter storms in the Midwest and Texas have delayed the delivery of 6 million doses of Covid-19 vaccine, affecting every US state, the nation’s leading health officials said on Friday.

The backlog equates to three days of late deliveries, Andy Slavitt, White House senior advisor on Covid’s response, said during a news conference.

“Many states have been able to cover some of this delay with existing inventory,” said Slavitt.

The late deliveries are due to three major weather-related throttling points in the vaccines distribution chain, he said. Delivery centers at UPS, FedEx and McKesson that have been hired to deliver the cans to the states have reported staff shortages.

Slavitt said her workers were “snowed in and unable to come to work to package the vaccines, administration kits and other supplies.”

Road closures have also held up delivery of the vaccines between manufacturing facilities and shipping centers. In addition, more than 2,000 vaccine distribution points cannot receive doses because they are in places that are hampered by power outages, he said.

Continue reading: Covid live updates: Scientists are pushing for an optimized vaccination process

Because of the strict cold chain requirements for storing the cans in extremely cold temperatures, it is better to withhold the shipments than to send them to places where the shots may expire if they cannot be administered within three days. He said the vaccines are “safe and sound sitting in our factories and hubs and ready to ship.”

“As weather conditions improve, we are already trying to clear that backlog,” Slavitt said, adding that 1.4 million cans will be shipped on Friday. He said the government expected “all residue cans will be delivered within the next week.”

“We assume that we can handle this backlog and the new production that goes online next week,” said Slavitt.

Ahead of Friday’s briefing, US officials raised the alarm that their vaccine shipments were delayed this week. The massive winter storm closed distribution centers, leaving millions of people in states like Texas, Louisiana and Mississippi without power.

The Chief Medical Officer of the White House, Dr. Anthony Fauci, warned Thursday that the power outages and winter storm in Texas are a “significant” problem for Covid-19 vaccine distribution this week. The Biden government is asking vaccination centers to extend their working hours and offer additional appointments in the coming days and weeks to catch up, Slavitt said on Friday.

“If we all work together, from the factory to the vaccines, we’ll make up for that in the coming week,” he said.

Slavitt announced Friday that the government is working with Florida and Pennsylvania to open five more vaccination centers.

Four of the five vaccination centers will be located in the cities of Jacksonville, Miami, Orlando and Tampa, Florida. The four locations can vaccinate a total of up to 12,000 people per day. The fifth center will be in Philadelphia and vaccinate 6,000 people a day.

Categories
Health

Folks Who Have Had Covid Ought to Get Single Vaccine Dose, Research Recommend

People Who Have Had Covid Should Get Single Vaccine Dose, Studies Suggest

Almost 30 million people in the United States – and likely many others whose diseases have never been diagnosed – have been infected with the coronavirus to date. Should these people still be vaccinated?

Two new studies answer this question with an emphatic yes.

In fact, research suggests that for these people, just one dose of the vaccine is enough to charge their antibodies and destroy the coronavirus – and even some other infectious variants.

The results of these new studies are consistent with the results of two others published in the past few weeks. Taken together, the research suggests that people who have had Covid-19 should be immunized – but a single dose of the vaccine may be enough.

“I think it’s a really strong rationale for why people who were previously infected with Covid should get the vaccine,” said Jennifer Gommerman, an immunologist at the University of Toronto who was not involved in the new research.

A person’s immune response to a natural infection varies widely. Most people make plenty of antibodies that last for many months. However, some people who have had mild or no symptoms of Covid-19 produce few antibodies that quickly drop to undetectable levels.

The vaccines “even hit the pitch,” said Dr. Gommerman, so that anyone who has recovered from Covid-19 will make enough antibodies to protect against the virus.

The latest study, which has not yet been published in a scientific journal, analyzed blood samples from people with Covid-19. The results suggest that her immune system would have problems fighting off B.1.351, the coronavirus variant first identified in South Africa.

But a shot of the Pfizer BioNTech or Moderna vaccine changed the picture dramatically: It increased the amount of antibodies in her blood by a thousand times – “a massive, massive surge,” said Andrew T. McGuire, immunologist at Fred Hutchinson Cancer Research Center in Seattle, who led the study.

Rinsed with antibodies, samples from all participants were able to neutralize not only B.1.351, but also the coronavirus that caused the SARS epidemic in 2003.

In fact, the antibodies appeared to work better than those in people who did not have Covid and had received two doses of a vaccine. Several studies have shown that the Pfizer-BioNTech and Moderna vaccines are about five times less effective against the variant.

The researchers received blood samples from 10 volunteers in the Seattle Covid Cohort Study who were vaccinated months after contracting the coronavirus. Seven of the participants received the Pfizer BioNTech vaccine and three received the Moderna vaccine.

Blood taken about two to three weeks after vaccination showed a significant increase in antibody levels compared to the samples taken before vaccination. The researchers don’t yet know how long the increased levels of antibodies will last, but “hopefully they will last,” said Dr. McGuire.

Updated

Apr. 19, 2021 at 12:01 am ET

The researchers also saw a surge in immune cells remembering and fighting the virus, said Dr. McGuire. “It looks pretty clear that we are boosting their pre-existing immunity,” he said.

In another new study, New York University researchers found that a second dose of the vaccine was of no great benefit at all for people with Covid-19 – a phenomenon that has also been seen with vaccines against other viruses.

In this study, most people had been infected with the coronavirus eight or nine months previously, but their antibodies increased hundreds to a thousand times with the first dose of a vaccine. However, after the second dose, the antibody levels did not rise any further.

“It is real evidence of the strength of immunological memory that they are given a single dose and have a huge increase,” said Dr. Mark J. Mulligan, director of the NYU Langone Vaccine Center and lead author of the study.

In some parts of the world, including the United States, a significant minority of the population is already infected, noted Dr. Mulligan firmly. “You should definitely be vaccinated,” he said.

It is unclear whether the thousand-fold increase in antibody levels recorded in the laboratory will occur in real-world environments. However, research shows that a single shot is enough to significantly raise antibody levels, said Florian Krammer, an immunologist at the Icahn School of Medicine on Mount Sinai in New York.

Dr. Krammer led another of the new studies that showed that people who had Covid-19 and received a dose of vaccine had more serious side effects from the vaccination and had more antibodies than those who had not been infected before.

“When you put all four papers together, you get pretty good information about people who have had an infection and only need one vaccination,” said Dr. Krammer.

He and other researchers are trying to convince scientists from the Centers for Disease Control and Prevention to recommend only one dose for those who have recovered from Covid-19.

Ideally, these people should be monitored after the first shot in case their antibody levels drop after a few weeks or months, said Dennis R. Burton, an immunologist at the Scripps Research Institute in La Jolla, California.

The fact that the charged antibodies seen in the new study can fight the 2003 SARS virus suggests that a single dose of the vaccine may have induced the volunteer’s bodies to produce “largely neutralizing antibodies” – immune molecules that are able to target a wide range of related antibodies to viruses, said Dr. Burton.

He and other scientists have spent decades investigating whether largely neutralizing antibodies can fight multiple versions of HIV at the same time. HIV mutates faster than any other virus and evades most antibodies quickly.

The new coronavirus is mutating much more slowly, but there are now several variants of the virus that appear to have become more contagious or which are thwarting the immune system. The new study could provide clues on how to make a single vaccine that stimulates the production of largely neutralizing antibodies that can destroy all variants of the coronavirus, said Dr. Burton.

Without such a vaccine, scientists would have to adjust the vaccines every time the virus changes significantly. “You’re kind of a whac-a-mole approach,” he said. It will likely take many months, if not more, to develop and test this type of vaccine against the coronavirus, but “this is the longer term way to approach this virus.”

Categories
Health

The second dose of Covid vaccine is required for full immunity, infectious illness specialist says

The second dose of Covid vaccine is needed for complete immunity, infectious disease specialist says

According to Dr. Paul Offit, director of the Vaccine Education Center at Philadelphia Children’s Hospital, the second dose of the Covid-19 vaccine is critical to creating longer and complete immunity as well as preventing variants of the virus.

“We need to know that this is a two-dose vaccine,” Offit told CNBC’s The News with Shepard Smith. “The second dose of the Pfizer or Modern vaccine increases it dramatically, inducing the type of cells that suggest you have longer long-term memory, which means the vaccine would last a few years. I think when we have humans Getting only one dose of the vaccine that gives you shorter and less complete immunity will only lead to variants. “

His comments came after a recent study suggested that the second shot of the Pfizer vaccine could be delayed as the first offered high protection, according to a letter published in the New England Journal of Medicine.

To date, more than 15 million people in the US have received both shots of a two-dose Covid vaccine, according to the Centers for Disease Control and Prevention. Almost 25 million additional people in the country have received their first vaccination shot.

Moderna said last month that it plans to test a booster shot of its Covid vaccine a year after the first two-dose immunization.

“If you get a booster shot of this virus, which is the most common virus in circulation and produces more cross-reactive antibodies … you don’t necessarily have to load up with another vaccine when a variant reaches the point of being completely resistant to immunity, then we have to develop the second generation vaccine, “said Offit. “Right now it could mean a booster shot of the vaccines we’ve already made.”

Subscribe to CNBC PRO for exclusive insights and analysis as well as live business day programs from around the world.

Categories
Health

Girl, 90, Walked Six Miles within the Snow for a Vaccine

Woman, 90, Walked Six Miles in the Snow for a Vaccine

To get her coronavirus vaccination last weekend, 90-year-old Frances H. Goldman reached an exceptional length: six miles. On foot.

It was too snowy to drive at 8:00 a.m. on Sunday when Ms. Goldman took out her walking sticks, dusted her snowshoes, and set off from her Seattle home on View Ridge. She made her way to the Burke-Gilman Trail on the outskirts of town, where it meandered south along a series of old railroad tracks. Then she crossed the residential streets of Laurelhurst to reach Seattle Children’s Hospital.

It was a quiet walk, said Mrs. Goldman. People were short. She caught a glimpse of Lake Washington through falling snow. It would have been more difficult, she said, had she not had a bad hip replaced last year.

In the hospital, about three miles and an hour from home, she received the shock. Then she bundled herself up again and went back the way she had come.

It was an extraordinary effort – but it wasn’t the extent. Ms. Goldman, who was eligible for a vaccine last month, had already tried everything to secure an appointment. She had made repeated phone calls and visited the websites of local pharmacies, hospitals and state health departments without success. She hired a daughter in New York and a friend in Arizona to find an appointment.

Finally, a visit to the Seattle Children’s Hospital website on Friday yielded results.

“Lo and behold, a whole list of times has surfaced,” she said in a telephone interview on Wednesday. “I couldn’t believe my eyes. I got my glasses to make sure I saw them properly. “

Then came the snow that would ultimately fall more than 10 inches on one of the snowiest Seattle weekends ever recorded. Mrs. Goldman was cautious about driving on hilly, unploughed roads and decided to walk to the hospital. On Saturday, she took a test walk to get a feel for how long the trip might take.

And on Sunday she went all the way to the hospital to get her vaccine.

The appointment went smoothly, she said. And it had special meaning to Ms. Goldman, because she could remember the joy of national celebrations in 1955 when another important vaccine was developed.

“I can remember the time when the polio vaccine was introduced,” Ms. Goldman said. She was a young mother at the time, and polio affected tens of thousands of children, sometimes resulting in paralysis or death. She recalls taking her children to get the vaccine at a school where she lived in Cincinnati.

This vaccine rollout “was done in a very organized way and made a huge difference in the way people can live in the summer – not only did people not get sick, but they didn’t have to live with the threat of getting sick . “

This time Ms. Goldman was disappointed with the vaccine distribution. “There’s no excuse for doing it the way it was,” she said. “It was disorganized. Completely disorganized. “

Seattle is just one of many places in the United States where residents have struggled to get access to the vaccine.

“There just aren’t enough vaccines across the state and nation,” said Sharon Bogan, a spokeswoman for the Seattle and King Counties Department of Health. “Even under the best of circumstances, we knew this would take time. We know eligible residents like Ms. Goldman have trouble accessing appointments due to limited availability of the vaccine. “

Its rollout in Washington state has been hampered by technology failures, equity bottlenecks, and persistent supply and demand imbalances. State officials have worked hard to put in place the infrastructure necessary to plan and vaccinate the millions of people who are already eligible.

And while similar stories have played out across the country, vaccine distribution in the US is slowly improving. President Biden said this week that any American who wanted a Covid-19 vaccination should have a vaccination by the end of July, but also warned that the logistics of distribution would continue to cause difficulties.

In King County, health officials grappling with limited supplies have worked to ensure the vaccine is administered fairly, according to Ms. Bogan. “We are focusing our efforts on those eligible high-risk individuals who are not affiliated with a doctor or the healthcare system and are establishing locations to reach older adults in communities disproportionately affected by Covid-19,” she said.

Ms. Goldman is expected to receive her second dose of vaccine next month. She plans to go.

And when it’s all over, she hopes to be able to take people back into her home, to resume volunteering at a nearby arboretum, and to hold onto her new great-grandchild, whom she hasn’t touched at all.

She is on the phone a lot at the moment – her long journey has been covered by numerous local and national news agencies. The attention, she said, has not bothered her so far.

“I hope it will inspire people to get their shots,” she said. “I think it’s important for the whole country.”

Sheelagh McNeill contributed to the research.

Categories
Health

N.Y.C. Covid Vaccine Disparities Revealed in ZIP Code Knowledge: Officers

N.Y.C. Covid Vaccine Disparities Revealed in ZIP Code Data: Officials

“The zip code data not only provides a map of where New Yorkers will be vaccinated, but also a roadmap for our Covid response,” said Dr. Easterling.

Also on Tuesday, Governor Andrew M. Cuomo released data showing that white people were vaccinated more frequently than expected in every region across the state. But in most regions, blacks were vaccinated at about half the expected rate.

In New York City, for example, 58 percent of those vaccinated were white, while white people made up just 52 percent of the eligible population, according to the state. About 14.4 percent of those vaccinated were black, although more than 30 percent of the eligible population were black.

About 16 percent of people vaccinated in the city were Hispanic or Latino, but Hispanic or Latino make up about 24 percent of the eligible population, according to the state.

Experts say people across the country who live in underserved areas face a variety of barriers to vaccination, including registration systems and websites that can take hours to navigate, lack of transportation, and difficulty getting off work to get one Chance to get. Given the history of unethical medical research in the United States, many people in color communities are more reluctant to get vaccinated.

Mr de Blasio said Tuesday that a new vaccination site opened on Wednesday at Teachers Preparatory High School in Brownsville, Brooklyn, open six days a week, giving priority to home health workers and those living in Brownsville and East New York.

“This is about addressing inequality and doing something very tangible about it,” he said.

Another new vaccination site will open at the Empire Outlets in Staten Island on Thursday, he said.

The city vaccinated 317,227 people last week, including 55,339 people in one day, de Blasio said, adding that more than 10 percent of New Yorkers would now have received at least one dose. He said the city could vaccinate far more people each day if it could get more doses from the federal government.

Categories
Business

Some Teenagers Volunteer for Covid Vaccine Trials to Get Their Lives Again

Some Teens Volunteer for Covid Vaccine Trials to Get Their Lives Back

“And I also thought it was important that people of different ages and races be represented,” added Audrey, who, like her brother, is Asian. (Her mother Rachel, a nurse researcher who volunteered to try a vaccination, asked that their last names be withheld for privacy reasons.)

Overall, the teenage studies may be less different because the adult study results showed no discernible difference in results by race. And because the adult studies have been so successful, up to two-thirds of teenagers may be offered the actual vaccine instead of a placebo.

Pfizer, whose study is fully enrolled, expects results from its studies for children ages 12-15 years old in the first quarter of this year to be submitted to the Food and Drug Administration for review. Moderna is still recruiting teenagers for its studies. The data is expected to be available this summer. Other companies expect to begin studies for teenagers soon. Shortly thereafter, researchers will open studies for children ages 5 and up, most likely at more modest doses.

As in any medical study, investigators are indifferent to discussing risks and benefits. Instead of teaching young subjects, Dr. Campbell, whose clinic will be conducting a Moderna study for younger children, puts her in conversation.

“Do you remember your tetanus shot? Tell me about it, ”he might say. And then: “So it’s similar and how is it different.” He wants to make sure that the teen is actively involved in the decision-making process. “We always say, ‘Don’t do this for your parents. ‘”

Dr. Sarah Hasan, senior recruiter for DM Clinical Research who oversees the Houston Fights Covid campaign and most of the city’s vaccine studies, said the educational sessions for teenagers and adults are quite different. She has more fun with the teenagers.

“Usually adults scan the form, ask a few questions, and they’re done,” she said. “But kids ask a lot more questions than adults and actually listen, which is pretty nice.”

Categories
Health

How CVS and different retailers will dole out any surplus Covid vaccine doses

How CVS and other retailers will dole out any surplus Covid vaccine doses

A health care worker wearing a protective mask fills a syringe with a dose of Pfizer-BioNTech Covid-19 vaccine at a large-scale vaccination site in Sacramento, Calif., On February 4, 2021.

David Paul Morris | Bloomberg | Getty Images

As the Covid-19 vaccination efforts begin at major retailers and pharmacies like CVS and Walgreens, what to do with excess vaccine becomes a bigger question.

Both versions of the vaccine must be stored at very low temperatures. Once thawed, the vaccine must be administered within hours. In addition, vaccine bottles contain multiple doses.

Companies told the Wall Street Journal that they are planning to use waiting lists and will consider vaccinating employees who are eligible when excess supplies become available. The aim is to avoid wasting doses that are still scarce.

Starting Thursday, vaccine doses will be sent to thousands of pharmacies and grocery stores such as CVS and Walmart across the US. This move starts with approximately 6,500 retail locations and will help accelerate adoption to ensure more Americans are protected from Covid-19.

The companies schedule appointments based on the amount of vaccine they receive at each location. However, you could get an excess vaccine if customers don’t show up for an appointment or if a vaccine bottle contains more vaccine than expected.

Currently, only two vaccines, one from Pfizer-BioNTech and one from Moderna, have received emergency use approval from the Food and Drug Administration. Both types require two doses of the shot to be effective.

Retailers must adhere to different state and local rules for licensing requirements when managing waiting lists and what to do with excess doses. In some states, retail workers qualify for the vaccine, while in other states they are not considered a high priority group unless they are over a certain age or have a specific illness.

A Walmart spokeswoman told the newspaper that the retailer has reached out to buyers or workers who qualify under a state’s guidelines to get vaccinated in the event of oversupply.

Walmart worked with state health departments on logs to avoid waste, a Walmart spokesman told CNBC. These protocols allow the administration of excess opened and available doses to individuals, including employees, who fall under authorized groups in order of priority.

A Walgreens spokesman told CNBC that they will consider their staff for the remaining doses and will communicate with state and local jurisdictions about any excess doses.

In the meantime, CVS pharmacists will keep a list of qualified patients by state and use that list to determine who will receive the remaining doses of the vaccine, CVS Health senior vice president Chris Cox told CNBC.

Read the full story in the Wall Street Journal.

Categories
Health

CDC to analyze demise of Nebraska man who acquired Covid vaccine dose

CDC to investigate death of Nebraska man who received Covid vaccine dose

Vials and a medical syringe are displayed in front of the Food and Drug Administration (FDA) US logo. The FDA finds the COVID-19 vaccine.

Pavlo Gonchar | LightRocket | Getty Images

The Centers for Disease Control and Prevention will investigate the death of a Nebraska man after local health officials listed the Covid-19 vaccine as one of several causes of death, the Nebraska Department of Health and Human Services said in a press release on late Thursday with.

The man, a long-term care facility in his late forties with multiple concurrent diseases and conditions, died on January 17 between one and two weeks after receiving his first dose of a Covid-19 vaccine.

The CDC and FDA received 1,170 reports of deaths in people in the United States who received Covid vaccine between December 14 and February 7 – 0.003% of those vaccinated. During that time, over 41 million doses of Pfizer or Moderna’s Covid were administered 19 vaccines across the country, according to the CDC.

“Typically, deaths from COVID-19 vaccines can be attributed to anaphylaxis and occur relatively soon after the vaccine is administered, so monitoring is done,” said Dr. Gary Anthone, Nebraska Chief Medical Officer.

“While I can’t speculate about this case, if people die days or weeks after being given the vaccine, it is more likely to be due to other underlying factors,” Anthone said.

The death was recorded on the Vaccine Adverse Event Reporting System, a national vaccination safety monitoring program run by the CDC and the Food and Drug Administration. All adverse events or deaths must be reported to the system if they occur after vaccination.

“This process enables the CDC and FDA to closely monitor and assess adverse events for ongoing safety assessments,” said a statement from the state health department.

The CDC has not reported any patterns for cause of death that would suggest safety issues with the vaccines.

People with high-risk diseases should consult their medical providers about vaccination, Anthone said.

Categories
Health

Biden Covid workforce holds briefing after securing extra vaccine doses

Biden Covid team holds briefing after securing more vaccine doses

[The stream is slated to start at 11 a.m. ET. Please refresh the page if you do not see a player above at that time.]

President Joe Biden’s Covid-19 Response Team is holding a press conference on Friday on the pandemic that infected more than 27 million Americans and killed at least 475,457 people in about a year.

Biden announced Thursday that his administration had signed contracts with Pfizer and Moderna for an additional 200 million doses of Covid-19 vaccine, bringing the US total to 600 million. Since both approved vaccines require two doses three to four weeks apart, a total of 600 million doses would be enough to vaccinate 300 million people.

In addition to securing more doses for states, the Biden government is using the military to support doses and is establishing mass vaccination centers across the country.

On Wednesday, the government announced it would work with Texas officials to build three new community vaccination centers in Dallas, Arlington and Houston. A few days earlier, the government had announced that it would send troops on active duty to California to help vaccination centers for Covid-19 employees.

Read CNBC’s live updates for the latest news on the Covid-19 outbreak.

Categories
Health

What you possibly can and may’t do after getting the Covid vaccine, in response to Dr. Kavita Patel

What you can and can't do after getting the Covid vaccine, according to Dr. Kavita Patel

Even after being fully vaccinated against Covid, some public health precautions will still be needed before further data can be collected on the vaccines, said Dr. Kavita Patel told CNBC on Friday.

It is clear that Pfizer and Moderna’s two-shot vaccines are highly effective in preventing serious illness and death from Covid-19, Patel said in a “Squawk Box” interview. Currently, it is less known how well the vaccines reduce coronavirus transmission.

In other words, someone who has been vaccinated has greatly reduced their risk of actually getting the coronavirus, but Patel claims that precautions will still be needed in the coming months when a small group gathers and one person in this one Group was not vaccinated.

“When you are in a household with young children [who don’t yet qualify for the vaccine] or even children at increased risk … or even yourself, if you are at increased risk despite being vaccinated, you should take precautions indoors while wearing masks. If possible, stay outdoors with people, ”said Patel, a Washington, DC family doctor and non-resident of the Brookings Institution.

“The only reason I’m saying this is that we need more data to understand the risk of transmission,” she added.

The Centers for Disease Control and Prevention this week updated their quarantine guidelines for people who have been fully vaccinated. Both Pfizer’s and Moderna’s vaccines require two doses for complete protection. The CDC now says people exposed to the coronavirus won’t need quarantine within three months of being fully vaccinated if they don’t develop symptoms.

Like Patel, the CDC recognizes that the risk of one vaccinated person passing the virus on to another is “uncertain”. The reason for the modified quarantine policy, according to the CDC, lies in the vaccines, which are highly effective in preventing the development of symptomatic Covid.

This is important because, according to the CDC, it is believed that people with Covid symptoms transmit the virus more than asymptomatic people. Because of this, the agency said a fully vaccinated person who shows no symptoms does not need to be quarantined.

The CDC defines full vaccination as two weeks after receiving the second vaccine with two doses, or two weeks after receiving a vaccine with a single vaccine. Johnson & Johnson has filed for emergency approval for its single-dose vaccine and an advisory panel will look into it at a meeting later this month.

Patel said she believes the CDC quarantine guide could be updated again if more Americans are vaccinated. But at this stage of the pandemic, she said, the US is in “an interim period.” Although she said roughly one in three Americans has either been vaccinated or developed natural antibodies to coronavirus because of a previous infection, “the other two people still have plenty of opportunities to encourage the virus to spread, especially given these more communicable variants. ” . “

To illustrate this, Patel offered insights into her personal approach to aspects of life after she was vaccinated. The former Obama administration official said she continues to wear a mask in public even though she is confident she will not get sick and die from Covid.

“I’m still doing all the things we’ve talked about – which we’re pretty tired of – until we have more data that I can’t give [the virus] someone who was not vaccinated, said Patel, who served as director of politics with the Obama White House Bureau of Interstate Affairs and Public Engagement, where she worked on health initiatives.

However, Patel said there are reasons to be optimistic and mentioned how she is thinking about the possibility of seeing her parents soon. “Because I’ve been vaccinated and after they went in a few weeks after that second dose, I’ll be more comfortable talking about risks because it’s not 100% that they don’t catch the virus, but I feel comfortable when I have a little meeting with them when we are all vaccinated together, “she said.

While vaccine availability is currently limited, Patel noted recent comments from Dr. Anthony Fauci on NBC’s “TODAY” Show. The nation’s leading expert on infectious diseases expects it to be “open season” for Covid vaccinations by April. If Fauci’s forecast comes true, Patel believes that by the summer more Americans will be able to gather together safely.

“As the months go by, more people in your household, and possibly in another household, like your parents or grandparents, will be vaccinated, which could make smaller gatherings safer,” said Patel. “We can look forward to that because we’ve been holding back for over a year, some of us, to see older parents and relatives at high risk.”